Degradation of the extracellular matrix is part of the pathology of ulcerative colitis

被引:22
|
作者
Kirov, Stefan [1 ]
Sasson, Ariella [1 ]
Zhang, Clarence [1 ]
Chasalow, Scott [1 ]
Dongre, Ashok [2 ]
Steen, Hanno [3 ,4 ,5 ]
Stensballe, Allan [6 ]
Andersen, Vibeke [7 ,8 ]
Birkelund, Svend [6 ]
Bennike, Tue Bjerg [3 ,4 ,5 ,6 ]
机构
[1] Bristol Myers Squib, Translat Bioinformat, Pennington, NJ 08534 USA
[2] Bristol Myers Squibb, Prot Sci, Pennington, NJ USA
[3] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA
[4] Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA
[5] Boston Childrens Hosp, Precis Vaccines Program, Boston, MA 02115 USA
[6] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark
[7] Hosp Southern Jutland, IRS Ctr Sonderjylland, Focused Res Unit Mol Diagnost & Clin Res MOK, Aabenraa, Denmark
[8] Univ Southern Denmark, Inst Mol Med, Odense, Denmark
关键词
INFLAMMATORY-BOWEL-DISEASE; EVIDENCE-BASED CONSENSUS; HUMAN CHROMOGRANIN-A; EPITHELIAL-CELLS; CROHNS-DISEASE; COLLAGEN; DIAGNOSIS; RISK; IBD; MANAGEMENT;
D O I
10.1039/c8mo00239h
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The scientific value of re-analyzing existing datasets is often proportional to the complexity of the data. Proteomics data are inherently complex and can be analyzed at many levels, including proteins, peptides, and post-translational modifications to verify and/or develop new hypotheses. In this paper, we present our re-analysis of a previously published study comparing colon biopsy samples from ulcerative colitis (UC) patients to non-affected controls. We used a different statistical approach, employing a linear mixed-effects regression model and analyzed the data both on the protein and peptide level. In addition to confirming and reinforcing the original finding of upregulation of neutrophil extracellular traps (NETs), we report novel findings, including that Extracellular Matrix (ECM) degradation and neutrophil maturation are involved in the pathology of UC. The pharmaceutically most relevant differential protein expressions were confirmed using immunohistochemistry as an orthogonal method. As part of this study, we also compared proteomics data to previously published mRNA expression data. These comparisons indicated compensatory regulation at transcription levels of the ECM proteins we identified and open possible new avenues for drug discovery.
引用
收藏
页码:67 / 76
页数:10
相关论文
共 50 条
  • [41] PET/MRI for evaluating subclinical inflammation of ulcerative colitis
    Shih, I-Lun
    Wei, Shu-Chen
    Yen, Rouh-Fang
    Chang, Chin-Chen
    Ko, Chi-Lun
    Lin, Been-Ren
    Shun, Chia-Tung
    Liu, Kao-Lang
    Wong, Jau-Min
    Chang, Yeun-Chung
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2018, 47 (03) : 737 - 745
  • [42] Impact of the age of diagnosis on the natural history of ulcerative colitis
    Goncalves, Tiago Curdia
    de Castro, Francisca Dias
    Machado, Joao Firmino
    Moreira, Maria Joao
    Rosa, Bruno
    Cotter, Jose
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2015, 107 (10) : 614 - 621
  • [43] Vedolizumab for the treatment of ulcerative colitis
    Stallmach, Andreas
    Schmidt, Carsten
    Teich, Niels
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 10 (02) : 165 - 175
  • [44] Current treatment of ulcerative colitis
    Meier, Johannes
    Sturm, Andreas
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (27) : 3204 - 3212
  • [45] Ulcerative Colitis: Shifting Sands
    D'Haens, Geert R. A. M.
    Lindsay, James O.
    Panaccione, Remo
    Schreiber, Stefan
    DRUGS IN R&D, 2019, 19 (02) : 227 - 234
  • [46] Surgical treatment of ulcerative colitis
    Kronberg, Udo
    REVISTA MEDICA CLINICA LAS CONDES, 2019, 30 (05): : 357 - 364
  • [47] Positioning Therapies in Ulcerative Colitis
    Danese, Silvio
    Fiorino, Gionata
    Peyrin-Biroulet, Laurent
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (06) : 1280 - +
  • [48] Pneumatosis intestinalis in ulcerative colitis
    Matsumoto, Ayako
    Isomoto, Hajime
    Shikuwa, Saburo
    Okamoto, Kenta
    Yamaguchi, Naoyuki
    Ohnita, Ken
    Mizuta, Yohei
    Fujii, Masahiro
    Kohno, Shigeru
    MEDICAL SCIENCE MONITOR, 2009, 15 (09): : CS139 - CS142
  • [49] Pharmacotherapy in Patients with Ulcerative Colitis
    Scherer, M.
    Hardt, J.
    Blozik, E.
    Preiss, J. C.
    Bokemeyer, B.
    Hueppe, A.
    Raspe, H.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2011, 49 (07): : 820 - 826
  • [50] Vedolizumab for the treatment of ulcerative colitis
    Shahidi, Neal
    Bressler, Brian
    Panaccione, Remo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (01) : 129 - 135